Abstract:Background and PurposeImpaired endothelium‐dependent relaxation (EDR) is a hallmark of endothelial dysfunction. A deficiency of tetrahydrobiopterin (BH4) causes endothelial NOS to produce ROS rather than NO. PPARδ is an emerging target for pharmacological intervention of endothelial dysfunction. Thus, the present study examined the role of PPARδ in the regulation of dihydrofolate reductase (DHFR), a key enzyme in the BH4 salvage pathway.Experimental ApproachGene expression was measured by using qRT‐PCR and western blotting. Biopterins and ROS were determined by using HPLC. NO was measured with fluorescent dye and electron paramagnetic resonance spectroscopy. Vasorelaxation was measured by Multi Myograph System.Key ResultsThe PPARδ agonist GW501516 increased DHFR and BH4 levels in endothelial cells (ECs). The effect was blocked by PPARδ antagonist GSK0660. Chromatin immunoprecipitation identified PPAR‐responsive elements within the 5′‐flanking region of the human DHFR gene. The promoter activity was examined with luciferase assays using deletion reporters. Importantly, DHFR expression was suppressed by palmitic acid (PA, a saturated fatty acid) but increased by docosahexaenoic acid (DHA, a polyunsaturated fatty acid). GSK0660 prevented DHA‐induced increased DHFR expression. Conversely, the suppressive effect of PA was mitigated by GW501516. In mouse aortae, GW501516 ameliorated the PA‐impaired EDR. However, this vasoprotective effect was attenuated by DHFR siRNA or methotrexate. In EC‐specific Ppard knockout mice, GW501516 failed to improve vasorelaxation.Conclusion and ImplicationsPPARδ prevented endothelial dysfunction by increasing DHFR and activating the BH4 salvage pathway. These results provide a novel mechanism for the protective roles of PPARδ against vascular diseases.

Protection of Endothelial Cells Against Ang II-induced Impairment: Involvement of Both PPARα and PPARγ Via PI3K/Akt Pathway

Rosiglitazone Via Upregulation of Akt/Enos Pathways Attenuates Dysfunction of Endothelial Progenitor Cells, Induced by Advanced Glycation End Products

PKC/NADPH Oxidase Are Involved in the Protective Effect of Pioglitazone in High Homocysteine-Induced Paracrine Dyfunction in Endothelial Progenitor Cells.

Rosiglitazone ameliorates the dysfunction of endothelial progenitor cells induced by advanced glycation end products

α-Lipoic acid Prevents Angiotensin II-induced Endothelial Dysfunction via Antioxidant Effect and PI3K/Akt/eNOS Signaling Pathway

Vitamin D Ameliorates Angiotensin II-Induced Human Endothelial Progenitor Cell Injury Via the PPAR-γ/HO-1 Pathway

The Protective Effects of Pioglitazone on Endothelial Function in Rats with Hypercholesterolemia

Effect of Rosiglitazone on the Expression of Endothelin-1 Gene and the Secretion of Tumor Nevrosis Factor-Alpha in Ang Ⅱ-Induced Human Umbilic Vein Endothelial Cells in Vitro

Rosiglitazone Via PPARγ-dependent Suppression of Oxidative Stress Attenuates Endothelial Dysfunction in Rats Fed Homocysteine Thiolactone.

Effects of combination of pioglitazone and rosuvastatin on rat adventitial fibroblasts oxidization and inflammation induced by Ang Ⅱ

The Inhibitory Effects Of Rosiglitazone On Cardiac Hypertrophy Through Modulating The Renin-Angiotensin System In Diet-Induced Hypercholesterolemic Rats

Insulin-like Growth Factor-1 Receptor Activation Prevents Hydrogen Peroxide-Induced Oxidative Stress, Mitochondrial Dysfunction and Apoptosis

Peroxisome Proliferator-Activated Receptor α Attenuates Hypertensive Vascular Remodeling by Protecting Vascular Smooth Muscle Cells from Angiotensin II-Induced ROS Production

Alpha-Linolenic Acid Exerts An Endothelial Protective Effect Against High Glucose Injury Via Pi3k/Akt Pathway

Angiotensin II-Derived Reactive Oxygen Species Promote Angiogenesis in Human Late Endothelial Progenitor Cells Through Heme Oxygenase-1 Via ERK1/2 and AKT/PI3K Pathways

PPARδ Agonist Prevents Endothelial Dysfunction Via Induction of Dihydrofolate Reductase Gene and Activation of Tetrahydrobiopterin Salvage Pathway

Relationship Between Protective Effects of Rosiglitazone on Endothelium and Endogenous Nitric Oxide Synthase Inhibitor in Streptozotocin-Induced Diabetic Rats and Cultured Endothelial Cells

Effect of Rosiglitazone on Hydrogen Peroxide-Induced Pig's Endothelial Cell Apoptosis

Epigallocatechin-3-Gallate Ameliorates Angiotensin II-Induced Oxidative Stress and Apoptosis in Human Umbilical Vein Endothelial Cells through the Activation of Nrf2/Caspase-3 Signaling

PPAR Agonists Ameliorate Endothelial Cell Activation via Inhibition of Diacylglycerol–Protein Kinase C Signaling Pathway

Nintedanib ameliorates oxidized low-density lipoprotein -induced inflammation and cellular senescence in vascular endothelial cells